Exact Sciences (EXAS) Tops Q3 EPS by 5c; Raises FY Rev Outlook
Tweet
Share
E-mail
Get Alerts EXAS Hot Sheet
Price: $104.91 --0%
Financial Fact:
Sales and marketing: 26.31M
Today's EPS Names:
MSGM, SMID, VISL, More
Financial Fact:
Sales and marketing: 26.31M
Today's EPS Names:
MSGM, SMID, VISL, More
Join SI Premium – FREE
Exact Sciences (NASDAQ: EXAS) reported Q3 EPS of ($0.37), $0.05 better than the analyst estimate of ($0.42). Revenue for the quarter came in at $118.3 million versus the consensus estimate of $109.31 million.
GUIDANCE:
Exact Sciences sees FY2018 revenue of $435-440 million, versus prior of $420-$430 million and the consensus of $428.75 million.
For earnings history and earnings-related data on Exact Sciences (EXAS) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Freightos Limited (CRGO) Tops Q2 EPS by 3c ; Offers Guidance
- L3Harris CEO steps down amid conduct review, shares drop
- InspireMD (NSPR) Tops Q2 EPS by 1c
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
